Arrhythmias & electrophysiology
Risk of death and thrombosis in patients admitted to the emergency department with supraventricular tachycardias
Authors' conclusion
The increased risk of adverse events in patients with SVT appears to be most pronounced in the short term and partly associated with the increased likelihood of incident AF.
Study context
- Population
- ED patients with supraventricular tachycardia (SVT), atrial fibrillation (AF), atrial flutter or controls, not taking OAC, identified by ICD codes in TriNetX
- Participants
- 23,524 / 5,413 / 157,715 / 150,807
- Exposure
- SVT vs controls, atrial flutter and AF
- SVTn = 23,524
- Atrial fluttern = 5,413
- AFn = 157,715
- Control (CTRL)n = 150,807
- Outcome
- Composite of:
- All-cause death
- Thromboembolism
- Follow-up
- 1 year
Methodological detailspropensity-score matched, TriNetX
- Propensity-score matched
- TriNetX
Main finding
As reported in the abstract
Hazard ratio (95% CI)
SVTvs CTRL
2.89(2.65–3.17)
SVTvs Atrial flutter
0.87(0.79–0.97)
SVTvs AF
0.69(0.65–0.73)
Observational data: associations, not effects.
Further findings
Composite outcome in SVT by time, sex, age, multimorbidity (subgroups) · first 30 days
- Risk in SVT more pronounced during first 30 days in males, age ≥65 years, or multimorbidity
Incident AF
- Increased risk of incident AF in SVT vs CTRL
Original publication
Risk of death and thrombosis in patients admitted to the emergency department with supraventricular tachycardias. Heart Rhythm. Published 28 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →